On April 2nd, Wang Yihua, Vice Chairman of the Standing Committee of the Shandong Provincial People's Congress and Member of the Party Leadership Group, led a team to conduct an on-site investigation at GGOG. Accompanying him were Wang Luming, Director of the Weihai Municipal People's Congress Standing Committee and Secretary of the Party Leadership Group, Xu Li, Deputy Secretary-General of the Standing Committee, Liu Bo, Director of the Urban Construction, Environmental Protection, and Resources Working Committee, and Tang Enzhi, Member of the Party Leadership Group and Deputy Director of the Weihai District People's Congress Standing Committee. Wu Yang, Deputy Chairman of GGOG, and Wu Bo, Executive Vice President, made special reports on the company's development situation on behalf of the company.
Under the accompaniment of Deputy Chairman Wu Yang and Executive Vice President Wu Bo, the provincial, municipal, and district leaders visited the Marine Biopharmaceutical Science and Technology Park's Marine Science Popularization Exhibition Center. Through on-site visits and in-depth exchanges, they thoroughly understood the current production and operation status, development achievements, and future planning of GGOG. They highly praised the company's strategic layout for building 'two parks and one base,' adopting a 'one-stop' full industrial chain development model, and upgrading products from industrial-grade to food-grade, and further to high-end marine biopharmaceuticals.
After the investigation, Vice Chairman Wang Yihua stated that GGOG is a directly connected enterprise under the Shandong Provincial People's Congress. This special visit was aimed at allowing everyone to gain a comprehensive understanding of the company. Everyone should provide all-around support to help the company perform better on its path to health. It is necessary to delve into enterprises to understand actual situations and solve practical problems, promoting faster development of enterprises, continuously improving new quality productivity levels, focusing on the implementation of the ocean strategy, creating new highlights for high-quality development of Shandong's marine industry, and striving to become a world-class full industrial chain marine biopharmaceutical enterprise.
